StockSelector.com
  Research, Select, & Monitor Sunday, August 25, 2019 1:56:49 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Haemonetics Corp.$130.15($3.65)(2.73%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Haemonetics Corp. has an overall rank of 1084 out of 7130 stocks based on 15 positive rankings and 7 negative rankings.

Positive Rankings
Positive Guidance
Within the past 90 days Haemonetics has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Beat Whisper
According to EarningsWhispers.com, Haemonetics beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
90 Day Gain
Haemonetics rank is 187
Low Put/Call
Haemonetics has a low Put/Call ratio of 0.09 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Haemonetics is ranked 242.
Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 3.36%. Among companies that have had their estimates raised within the past month, Haemonetics is ranked 293.
Estimated EPS Growth
Haemonetics rank is 303
Up EPS Surprise
Haemonetics beat the consensus earnings estimate when it last reported quarterly earnings.
Target Prices
The average analysts' target price is $139.00 for Haemonetics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Haemonetics is ranked 1103.
Estimated Revenue Growth
Haemonetics rank is 1174
Highest Net Margin
Haemonetics rank is 1387
Highest ROA
Haemonetics rank is 1624
Historic EPS Growth
Haemonetics rank is 1772
Debt-to-Equity
Haemonetics rank is 1835
Highest ROE
Haemonetics rank is 2176
Historic Revenue Growth
Haemonetics rank is 2889
Negative Rankings
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Haemonetics is ranked 57.
Price-to-Book
Haemonetics rank is 410
High vPut/Call
Haemonetics has a high Put/Call ratio of 2.29 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Haemonetics is ranked 571.
Price-to-Sales
Haemonetics rank is 737
Negative Cash Growth
Haemonetics rank is 1820
10 Day Loss
Haemonetics rank is 2427







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.